The association between pathologic complete response (pCR) following to
neoadjuvant chemotherapy (NAC) and the improved survival in breast cancer has
been previously reported. The aim of this study was is to explore the expression
of several biomarkers described during epithelial-mesenchymal transition (EMT)
and the achievement of pCR in different molecular subtypes of breast cancer. We
identified archived pathology tissue from patients with breast cancer who
received NAC during the year 2014. We performed immunohistochemical analysis of
vimentin, nuclear factor κB (NF-κB), epidermal growth factor receptor (EGFR),
E-cadherin, estrogen receptor (ER), progesterone receptor, and Her2neu and
studied the association between the expression of these markers and pCR. A
Fisher exact test for categorical cofactors, an unpaired t test
and a nonparametric Wilcoxon test for continuous cofactors were used. The
results showed a significant expression of vimentin in triple-negative breast
cancer (TNBC; P = .023). An inverse correlation between
vimentin and the ER expression (P = .032) was observed. No
significant association was noted for vimentin, NF-κB, EGFR, and E-cadherin was
associated with pCR. This study suggests that the evaluated EMT related
biomarkers are not associated with pCR after NAC chemotherapy in an unselected
breast cancer population. Vimentin and NF-κB expressions were associated with
TNBC and could be further explored as potential therapeutic targets in this
subgroup. A prevalence of vimentin and NF-κB among Hispanic patients with breast
cancer warrants further investigation as a possibly contributing to the
prevalence of TNBC and adverse prognosis in this population.
Background: E-cigarette and vaping use-associated acute lung injury (EVALI) has been recently recognized as a complication in individuals who use vaping devices. Another consideration is that EVALI may have an adverse influence on the outcome of intercurrent respiratory infections. We document this deadly combination in the case of a young man who had EVALI and simultaneous Influenza-A infection leading to severe Acute Respiratory Distress Syndrome (ARDS). Case presentation: A 27-year-old male with a history of tobacco and vaping use was admitted to hospital after two weeks of flu-like symptoms, diarrhea and vomiting. A chest x-ray was consistent with multifocal pneumonia, and microbiological tests were positive for Influenza-A and methicillin-sensitive Staphalacoccus aureus (MSSA). Bronchoscopy provided evidence of acute inhalational injury. After admission, he acutely decompensated with severe hypoxia and hypotension; he required intubation, sedation and vasopressors. He developed sepsis with acute kidney failure, liver failure, biventricular systolic dysfunction and severe rhabdomyolysis. He was placed on veno-venous (VV) extracorporeal membrane oxygenation (ECMO) initially and later changed to Veno-Arterial (VA) ECMO. Nevertheless, the patient continued to deteriorate, and he expired two weeks after admission. Conclusion: This case documents that EVALI can act as a major factor leading a respiratory infection to progress into severe ARDS with a fatal outcome.
This analysis confirms that Hispanics/Latinas are diagnosed with breast cancer at a younger age and are more commonly uninsured than Non-Hispanics. We did not observe significant differences in the prevalence of ER+, triple negative or Her2 -neu positive disease or stages at presentation between the 2 groups in this cohort, however the non-Hispanic group was constituted only 14% of the studied population. A larger multi-institutional comparative study is being conducted to confirm these findings.
This study demonstrates the relation between VEGF expression and the activated HSCs denoted by the expression of α-SMA in CHC biopsies and together can be used as a predictor for the progression of fibrosis.
Chromosomal rearrangement involving the KMT2A gene is one of the most common genetic alteration in acute myeloid leukemia. A total of 135 different KMT2A rearrangements have been identified, where 94 translocation partner genes are now characterized at the molecular level. Of these 94 translocation partner genes, 35 translocation partner genes occur recurrently, but only 9 specific gene fusions account for more than 90% of cases. Translocation of KMT2A with SEPT5 gene at 22q11.2 is rare, with few reported cases in the literature. In this report, we are presenting a case of KMT2A-SEPT5 fusion in de novo acute myeloid leukemia with t(11;22)(q23;q11.2) with a review of the literature.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.